Register / Log In

OWL honors Dr. Marguerite McDonald

Bodega Bay, CA—Marguerite McDonald, MD, an ophthalmologist with Ophthalmic Consultants of Long Island, has been named the recipient of the Ophthalmic Women Leaders (OWL) 2012 Visionary Woman Award.

This is the first year for the award, which is expected to become an annual honor for extraordinary nominees who have worked to advance women in eye care.

“As our winner, Marguerite McDonald exemplifies what the Visionary Woman Award was created to celebrate,” said OWL President Jan Beiting. “Along with being noted for performing the first laser vision correction procedure and elected as the first female president of American Society of Cataract and Refractive Surgery (ASCRS) and the International Society of Refractive Surgery, she takes an active role in advancing women’s careers through mentoring. She is a trailblazer in every way.”

The award will be presented at OWL's signature reception on Monday, April 23 at the Hilton Chicago. The reception, in addition to several other OWL programs, is being held in conjunction with the ASCRS conference in Chicago. Details and registration for the Visionary Woman Award reception and other OWL programs can be found at

For more articles in this issue of Ophthalmology Times eReport, click here.

Results of motor vehicles agency-administered vision tests do not necessarily reflect fitness to drive, according to a study published in Investigative Ophthalmology & Visual Science.

A diet rich in zinc, vitamins C and E, lutein, zeaxanthin, and long-chain omega-3 fatty acids promotes health in the aging eye, according to a multidisciplinary roundtable of experts convened by the Ocular Nutrition Society and representing the fields of ophthalmology, optometry, diet and nutrition, and primary care.

Patients taking oral fluoroquinolones have a higher risk of developing a retinal detachment compared with those who are not taking them, according to a study recently published in the Journal of the American Medical Association.

OptiMedica Corp. has announced that its proprietary platform that combines a femtosecond laser, integrated three-dimensional optical coherence tomography (OCT) imaging, and a proprietary pattern-scanning technology (Catalys Precision Laser System) has been granted CE mark approval for creating single-plane and multi-plane arc cuts/incisions in the cornea during cataract surgery.

MacuCLEAR Inc. is beginning phase III studies for its lead compound, MC-1101, for the treatment of early-stage (dry) age-related macular degeneration (AMD).